TNFSF11 and cystic fibrosis: In the bone, the clinical presentation of serum overexpression of RANKL is an increased activity of OCs, resulting in bone loss; this is also evident in other degenerative diseases, such as osteoporosis, rheumatoid and psoriatic arthritis, in addition to CF [41,42,43].